Information about GPI
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0801.925.031

VAT liability
Yes
Established
22-05-2023
Last balance sheet year
2025
Company size
Small 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Full name
Genappe Pharma Invest
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from GPI

2025 2024 2023
Income statement
Profit/Loss € 18,412 146% € 7,471 146% € 3,035
Gross margin € 46,650 32% € 35,413 195% € 11,994
Balance sheet
Balance sheet total € 1,208,061 0% € 1,210,480 -1% € 1,224,051
Equity € 78,918 30% € 60,506 14% € 53,035
Debts € 1,129,143 -2% € 1,149,974 -2% € 1,171,016

Publications from GPI

Date Publication
24-05-2023 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Genappe Pharma Invest?
The VAT number of Genappe Pharma Invest is BE 0801.925.031.
Wat is the PEPPOL ID of Genappe Pharma Invest?
The PEPPOL ID of Genappe Pharma Invest is 0208:0801925031. Log in or start a free trial to see the full overview.
When was Genappe Pharma Invest founded?
Genappe Pharma Invest was founded on 22-05-2023.
What is the address of Genappe Pharma Invest?
The current registered office of Genappe Pharma Invest is located at Rue de Charleroi 65/Boite 1, 1470 Genappe.
When was the last time Genappe Pharma Invest filed their annual financial statements?
The most recent financial statements of Genappe Pharma Invest were filed on 03-07-2026.
How many employees does Genappe Pharma Invest have?
There are currently no employees working at Genappe Pharma Invest or no workforce information is available.
What is the annual turnover of Genappe Pharma Invest?
At the time of its most recent financial statements, Genappe Pharma Invest did not publish any turnover figures. Genappe Pharma Invest reported a gross margin of €46,649.79.

Sources